help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'DONNELL, D. E.
Right arrow Articles by WEBB, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'DONNELL, D. E.
Right arrow Articles by WEBB, K. A.

Am. J. Respir. Crit. Care Med., Volume 163, Number 4, March 2001, 892-898

Effects of Hyperoxia on Ventilatory Limitation During Exercise in Advanced Chronic Obstructive Pulmonary Disease

DENIS E. O'DONNELL, CHRISTINE D'ARSIGNY, and KATHERINE A. WEBB

Respiratory Investigation Unit, Department of Medicine, Queen's University, Kingston, Ontario, Canada

We studied interrelationships between exercise endurance, ventilatory demand, operational lung volumes, and dyspnea during acute hyperoxia in ventilatory-limited patients with advanced chronic obstructive pulmonary disease (COPD). Eleven patients with COPD (FEV1.0 = 31 ± 3% predicted, mean ± SEM) and chronic respiratory failure (PaO2 52 ± 2 mm Hg, PaCO2 48 ± 2 mm Hg) breathed room air (RA) or 60% O2 during two cycle exercise tests at 50% of their maximal exercise capacity, in randomized order. Endurance time (Tlim), dyspnea intensity (Borg Scale), ventilation (V E), breathing pattern, dynamic inspiratory capacity (ICdyn), and gas exchange were compared. PaO2 at end-exercise was 46 ± 3 and 245 ± 10 mm Hg during RA and O2, respectively. During O2, Tlim increased 4.7 ± 1.4 min (p < 0.001); slopes of Borg, V E, V CO2, and lactate over time fell (p < 0.05); slopes of Borg-V E, V E-V CO2, V E-lactate were unchanged. At a standardized time near end-exercise, O2 reduced dyspnea 2.0 ± 0.5 Borg units, V CO2 0.06 ± 0.03 L/min, V E 2.8 ± 1.0 L/min, and breathing frequency 4.4 ± 1.1 breaths/min (p < 0.05 each). ICdyn and inspiratory reserve volume (IRV) increased throughout exercise with O2 (p < 0.05). Increased ICdyn was explained by the combination of increased resting IRV and decreased exercise breathing frequency (r2 = 0.83, p < 0.0005). In conclusion, improved exercise endurance during hyperoxia was explained, in part, by a combination of reduced ventilatory demand, improved operational lung volumes, and dyspnea alleviation.




This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
J. B. West, P. D. Wagner, J. A. Neder, G. L. Scano, N. L. Jones, S. G. Zakynthinos, I. Vogiatzis, L. Nici, P. M. Calverley, H. R. Gosker, et al.
The major limitation to exercise performance in COPD is inadequate energy supply to the respiratory and locomotor muscles vs. lower limb muscle dysfunction vs. dynamic hyperinflation
J Appl Physiol, August 1, 2008; 105(2): 758 - 762.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
E. M. Clini and N. Ambrosino
Nonpharmacological treatment and relief of symptoms in COPD
Eur. Respir. J., July 1, 2008; 32(1): 218 - 228.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
I. Vogiatzis, G. Stratakos, D. Athanasopoulos, O. Georgiadou, S. Golemati, A. Koutsoukou, I. Weisman, C. Roussos, and S. Zakynthinos
Chest wall volume regulation during exercise in COPD patients with GOLD stages II to IV
Eur. Respir. J., July 1, 2008; 32(1): 42 - 52.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
D Jensen, K Amjadi, V Harris-McAllister, K A Webb, and D E O'Donnell
Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD
Thorax, July 1, 2008; 63(7): 606 - 613.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. Albert and P. M. A. Calverley
Drugs (including oxygen) in severe COPD
Eur. Respir. J., May 1, 2008; 31(5): 1114 - 1124.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
V. Kim, J. O. Benditt, R. A. Wise, and A. Sharafkhaneh
Oxygen Therapy in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, May 1, 2008; 5(4): 513 - 518.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
E. G. Collins, W. E. Langbein, L. Fehr, S. O'Connell, C. Jelinek, E. Hagarty, L. Edwards, D. Reda, M. J. Tobin, and F. Laghi
Can Ventilation-Feedback Training Augment Exercise Tolerance in Patients with Chronic Obstructive Pulmonary Disease?
Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 844 - 852.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al.
Outcomes for COPD pharmacological trials: from lung function to biomarkers
Eur. Respir. J., February 1, 2008; 31(2): 416 - 469.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
N. Ambrosino and R. Goldstein
Series on comprehensive management of end-stage COPD
Eur. Respir. J., November 1, 2007; 30(5): 828 - 830.
[Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
R. ZuWallack
The Nonpharmacologic Treatment of Chronic Obstructive Pulmonary Disease: Advances in Our Understanding of Pulmonary Rehabilitation
Proceedings of the ATS, October 1, 2007; 4(7): 549 - 553.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. D. Marciniuk, S. J. Butcher, J. K. Reid, G. F. MacDonald, N. D. Eves, R. Clemens, and R. L. Jones
The Effects of Helium-Hyperoxia on 6-min Walking Distance in COPD: A Randomized, Controlled Trial
Chest, June 1, 2007; 131(6): 1659 - 1665.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
D. E. O'Donnell, R. B. Banzett, V. Carrieri-Kohlman, R. Casaburi, P. W. Davenport, S. C. Gandevia, A. F. Gelb, D. A. Mahler, and K. A. Webb
Pathophysiology of Dyspnea in Chronic Obstructive Pulmonary Disease: A Roundtable
Proceedings of the ATS, May 1, 2007; 4(2): 145 - 168.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. L. Ries, G. S. Bauldoff, B. W. Carlin, R. Casaburi, C. F. Emery, D. A. Mahler, B. Make, C. L. Rochester, R. ZuWallack, and C. Herrerias
Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines
Chest, May 1, 2007; 131(5_suppl): 4S - 42S.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
O. Georgiadou, I. Vogiatzis, G. Stratakos, A. Koutsoukou, S. Golemati, A. Aliverti, C. Roussos, and S. Zakynthinos
Effects of rehabilitation on chest wall volume regulation during exercise in COPD patients
Eur. Respir. J., February 1, 2007; 29(2): 284 - 291.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. M. Bradley, T. Lasserson, S. Elborn, J. MacMahon, and B. O'Neill
A Systematic Review of Randomized Controlled Trials Examining the Short-term Benefit of Ambulatory Oxygen in COPD
Chest, January 1, 2007; 131(1): 278 - 285.
[Abstract] [Full Text] [PDF]

Home page
 ERRHome page
D. E. O'Donnell and P. Laveneziana
Physiology and consequences of lung hyperinflation in COPD
Eur. Respir. Rev., December 1, 2006; 15(100): 61 - 67.
[Abstract] [Full Text] [PDF]

Home page
 ERRHome page
P. M. A. Calverley
Exercise and dyspnoea in COPD
Eur. Respir. Rev., December 1, 2006; 15(100): 72 - 79.
[Abstract] [Full Text] [PDF]

Home page
 ERRHome page
E. F. M. Wouters
Nonpharmacological modulation of dynamic hyperinflation
Eur. Respir. Rev., December 1, 2006; 15(100): 90 - 96.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
D. E. O'Donnell, A. L. Hamilton, and K. A. Webb
Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD
J Appl Physiol, October 1, 2006; 101(4): 1025 - 1035.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
N. D. Eves, S. R. Petersen, M. J. Haykowsky, E. Y. Wong, and R. L. Jones
Helium-Hyperoxia, Exercise, and Respiratory Mechanics in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., October 1, 2006; 174(7): 763 - 771.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. L. Croxton, W. C. Bailey, and for the NHLBI Working Group on Long-term Oxygen Tr
Long-term Oxygen Treatment in Chronic Obstructive Pulmonary Disease: Recommendations for Future Research: An NHLBI Workshop Report
Am. J. Respir. Crit. Care Med., August 15, 2006; 174(4): 373 - 378.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. Nici, C. Donner, E. Wouters, R. Zuwallack, N. Ambrosino, J. Bourbeau, M. Carone, B. Celli, M. Engelen, B. Fahy, et al.
American thoracic society/european respiratory society statement on pulmonary rehabilitation.
Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1390 - 1413.
[Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
P. M. A. Calverley
Dynamic Hyperinflation: Is It Worth Measuring?
Proceedings of the ATS, May 1, 2006; 3(3): 239 - 244.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. A. Wedzicha
Heliox in chronic obstructive pulmonary disease: lightening the airflow.
Am. J. Respir. Crit. Care Med., April 15, 2006; 173(8): 825 - 826.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
E. A. Laude, N. C. Duffy, C. Baveystock, B. Dougill, M. J. Campbell, R. Lawson, P. W. Jones, and P. M. Calverley
The Effect of Helium and Oxygen on Exercise Performance in Chronic Obstructive Pulmonary Disease: A Randomized Crossover Trial
Am. J. Respir. Crit. Care Med., April 15, 2006; 173(8): 865 - 870.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
D. E. O'Donnell
Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease.
Proceedings of the ATS, January 1, 2006; 3(2): 180 - 184.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
E. F. McKone, S. C. Barry, M. X. FitzGerald, and C. G. Gallagher
Role of arterial hypoxemia and pulmonary mechanics in exercise limitation in adults with cystic fibrosis
J Appl Physiol, September 1, 2005; 99(3): 1012 - 1018.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
T. Higenbottam
Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease: A Case for Treatment
Proceedings of the ATS, April 1, 2005; 2(1): 12 - 19.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. M. A. Calverley and N. G. Koulouris
Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology
Eur. Respir. J., January 1, 2005; 25(1): 186 - 199.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
P. Palange, G. Valli, P. Onorati, R. Antonucci, P. Paoletti, A. Rosato, F. Manfredi, and P. Serra
Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients
J Appl Physiol, November 1, 2004; 97(5): 1637 - 1642.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
W. Chatila, T. Nugent, G. Vance, J. Gaughan, and G. J. Criner
The Effects of High-Flow vs Low-Flow Oxygen on Exercise in Advanced Obstructive Airways Disease
Chest, October 1, 2004; 126(4): 1108 - 1115.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
I. Vogiatzis, S. Nanas, E. Kastanakis, O. Georgiadou, O. Papazahou, and Ch. Roussos
Dynamic hyperinflation and tolerance to interval exercise in patients with advanced COPD
Eur. Respir. J., September 1, 2004; 24(3): 385 - 390.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
N. Ambrosino and S. Strambi
New strategies to improve exercise tolerance in chronic obstructive pulmonary disease
Eur. Respir. J., August 1, 2004; 24(2): 313 - 322.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
N J Stevenson and P M A Calverley
Effect of oxygen on recovery from maximal exercise in patients with chronic obstructive pulmonary disease
Thorax, August 1, 2004; 59(8): 668 - 672.
[Abstract] [Full Text] [PDF]

Home page
 Chronic Respiratory DiseaseHome page
N Ambrosino, D Giannini, and I D'Amico
How good is the evidence for ambulatory oxygen in chronic obstructive pulmonary disease
Chronic Respiratory Disease, July 1, 2004; 1(3): 125 - 126.
[PDF]

Home page
 Chronic Respiratory DiseaseHome page
B O'Neill, J M Bradley, A M McKevitt, L Heaney, M Riley, V McGovem, and J MacMahon
Prescribing practice for intermittent oxygen therapy: a GP survey
Chronic Respiratory Disease, July 1, 2004; 1(3): 139 - 142.
[Abstract] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
V. Brusasco and R. Pellegrino
Oxygen in the Rehabilitation of Patients with Chronic Obstructive Pulmonary Disease: An Old Tool Revisited
Am. J. Respir. Crit. Care Med., November 1, 2003; 168(9): 1021 - 1022.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
F. Laghi and M. J. Tobin
Disorders of the Respiratory Muscles
Am. J. Respir. Crit. Care Med., July 1, 2003; 168(1): 10 - 48.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
F. Gigliotti, C. Coli, R. Bianchi, I. Romagnoli, B. Lanini, B. Binazzi, and G. Scano
Exercise Training Improves Exertional Dyspnea in Patients With COPD: Evidence of the Role of Mechanical Factors
Chest, June 1, 2003; 123(6): 1794 - 1802.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
ATS/ACCP Statement on Cardiopulmonary Exercise Testing
Am. J. Respir. Crit. Care Med., January 15, 2003; 167(2): 211 - 277.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
O. Diaz, P. Begin, B. Torrealba, E. Jover, and C. Lisboa
Effects of noninvasive ventilation on lung hyperinflation in stable hypercapnic COPD
Eur. Respir. J., December 1, 2002; 20(6): 1490 - 1498.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. A. Dempsey
Exercise Carbon Dioxide Retention in Chronic Obstructive Pulmonary Disease: A Case for Ventilation/Perfusion Mismatch Combined with Hyperinflation
Am. J. Respir. Crit. Care Med., September 1, 2002; 166(5): 634 - 635.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. E. O'Donnell, C. D'Arsigny, M. Fitzpatrick, and K. A. Webb
Exercise Hypercapnia in Advanced Chronic Obstructive Pulmonary Disease: The Role of Lung Hyperinflation
Am. J. Respir. Crit. Care Med., September 1, 2002; 166(5): 663 - 668.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
F. Ortega, J. Toral, P. Cejudo, R. Villagomez, H. Sanchez, J. Castillo, and T. Montemayor
Comparison of Effects of Strength and Endurance Training in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., September 1, 2002; 166(5): 669 - 674.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2001
Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 642 - 662.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. E. O'DONNELL, S. M. REVILL, and K. A. WEBB
Dynamic Hyperinflation and Exercise Intolerance in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., September 1, 2001; 164(5): 770 - 777.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2001 American Thoracic Society 		  ATS State of the Art 2009